Skip to main content

Cipla 445 Pill - blue capsule/oblong, 22mm

Pill with imprint Cipla 445 is Blue, Capsule/Oblong and has been identified as Atazanavir Sulfate 200 mg. It is supplied by Cipla USA Inc.

Atazanavir is used in the treatment of HIV Infection; Nonoccupational Exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 445

Atazanavir sulfate 200 mg Cipla 445
Atazanavir sulfate 200 mg Cipla 445

Atazanavir Sulfate

Cipla 445
200 mg
22.00 mm
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
Inactive Ingredients
lactose monohydrate, crospovidone, magnesium stearate, gelatin, sodium lauryl sulfate, FD&C Blue No. 1, FD&C Red No. 3, FD&C Red No. 4, titanium dioxide, D&C Yellow No. 10, shellac, alcohol, isopropyl alcohol, butyl alcohol, propylene glycol, ammonia, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.